← Back to Search

NeuroVax for Multiple Sclerosis

Phase 2 & 3
Waitlist Available
Research Sponsored by Immune Response BioPharma, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 weeks
Awards & highlights

Study Summary

This trial is studying a vaccine called NeuroVax to see if it is better than a placebo at treating people with secondary progressive multiple sclerosis.

Eligible Conditions
  • Multiple Sclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The primary objective is to compare between treatment groups the cumulative number of new gadolinium enhancing (Gd+) lesions on brain MRI at up to 48 weeks in subjects with secondary progressive MS
Secondary outcome measures
Analyses of clinical relapses
Immunologic evaluations
Measures of neurologic disability EDSS score
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: NeuroVaxExperimental Treatment1 Intervention
NeuroVax
Group II: IFA PlaceboPlacebo Group1 Intervention
IFA Placebo

Find a Location

Who is running the clinical trial?

Immune Response BioPharma, Inc.Lead Sponsor
4 Previous Clinical Trials
688 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
162 Patients Enrolled for Multiple Sclerosis
croAMBIG
1 Previous Clinical Trials
150 Total Patients Enrolled
1 Trials studying Multiple Sclerosis
150 Patients Enrolled for Multiple Sclerosis
Richard M Bartholomew, Ph.DStudy DirectorImmune Response BioPharma, Inc.
2 Previous Clinical Trials
162 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
162 Patients Enrolled for Multiple Sclerosis
~39 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top